Focus:
AI
-
10 June 2019
Janssen partners with nference for AI-based drug development
Janssen Research & Development has collaborated with software solutions provider nference to leverage artificial intelligence (AI) and data sciences for the discovery and clinical development of drugs.
-
4 June 2019
Lilly and Atomwise partner to use AI for drug discovery
Eli Lilly has formed a multi-target alliance with start-up Atomwise to support preclinical drug discovery efforts.
-
21 May 2019
Schrödinger raises $110m to develop drug discovery platform
Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
-
1 May 2019
AstraZeneca forms drug discovery alliance with BenevolentAI
AstraZeneca has partnered with artificial intelligence (AI) company BenevolentAI to develop treatments for chronic kidney disease and idiopathic pulmonary fibrosis.
-
30 April 2019
Janssen to use Iktos’ AI technology for drug discovery
Janssen Pharmaceutica has initiated a collaboration agreement to use Iktos’ artificial intelligence (AI) technology to accelerate small molecule drug discovery.
-
28 March 2019
How machine learning and IoT can help the world’s poorest people
Plummeting cost-to-compute is making machine learning and IoT applications more accessible than ever. Here's why that could benefit soceity's poorest.
-
27 March 2019
Blue Brain Project clarifies neurons’ structure and role in disease
Swiss Ecole Polytechnique Fédérale de Lausanne (EPFL)’s Blue Brain Project has used a mathematical algorithm to distinguish the shape and structures of pyramidal cells.
-
25 March 2019
How government policy has shaped China’s pharma phenomenon
After many decades of growth, China is now the second largest global pharmaceutical market. Since the Chinese state closely controls the country’s economy, it’s unsurprising that government reforms have been...
-
22 March 2019
Genomics England signs immunotherapy partnership with CCG
NHS England spin-out Genomics England and artificial intelligence (AI)-focused Cambridge Cancer Genomics (CCG.ai) have announced they have entered into an immunology partnership.
-
21 March 2019
Celgene partners with AI drug discovery startup to make drug trials shorter
Biotechnology company Celgene has partnered with Exscientia to shorten the time it takes to get new treatments to market using AI drug discovery.
Close
Close
Close
Go Top
